Essilor® Stellest® Lenses
The first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children.
Essilor® Stellest® lenses slowed myopia progression by 71% on average over 2 years.
The first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children.
Essilor® Stellest® lenses slowed myopia progression by 71% on average over 2 years.